TYK2 and neoplasm: IVIS data showed a strongly increased tumor burden in TYK2-/- host mice compared to littermate control host mice (TYK2+/+) three weeks post injection (Figure 1a), which was confirmed by macroscopic inspection of livers four weeks post injection (Figure 1b).